<DOC>
	<DOCNO>NCT02898779</DOCNO>
	<brief_summary>To investigate comparative tolerability , metabolism pharmacokinetics individual enantiomer PQ healthy human volunteer . The specific aim comparative evaluation metabolism , pharmacokinetic behavior , tolerability isomer PQ ( RPQ SPQ racemic mixture RSPQ ) normal healthy human volunteer .</brief_summary>
	<brief_title>Metabolism Pharmacokinetics Primaquine Enantiomers Human Volunteers , Study 1</brief_title>
	<detailed_description>The primary objective project investigate comparative tolerability , metabolism pharmacokinetics individual enantiomer PQ healthy human volunteer . The overall approach follow : 36 healthy volunteer document normal G6PD activity , administer single oral dose RPQ , SPQ , RSPQ . At various time dose , draw blood sample , record plasma level parent drug , along plasma urinary metabolite . The comparative pharmacokinetics , tolerability hematological effect two enantiomer racemate assess .</detailed_description>
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Primaquine</mesh_term>
	<criteria>Adults ( 1860 year age ) Informed consent Healthy Known history liver , kidney hematological disease ; know history cardiac disease , arrhythmia , QT prolongation ; Autoimmune disorder ; Report active infection ; Evidence G6PD deficiency</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>